Company & Sponsor Intelligence

University of Florida

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials12

Recruiting1

Completed10

Countries1

Therapeutic footprint

alzheimersautismdementia_otherdepressionepilepsyneurodevelopmental_otherother_neurologyparkinsonssubstance_use

Indexed studies

NCT05201703Fycompa in Catamenial Epilepsy
epilepsy · United StatesPHASE4

NCT02453763In Vivo Imaging of Therapeutic Electric Current Flow
alzheimers · United StatesCOMPLETED

NCT04829656The PACE-DLB Study
dementia_other · United StatesCOMPLETED

NCT04795908Combined CBIT and rTMS to Improve Tourette's Syndrome
neurodevelopmental_other · United StatesNA

NCT06688357Revitalize Cognition: Near Infrared Stimulation in Parkinson Patients
parkinsons · United StatesNA

NCT04836715Prevalence of Visual Dysfunction in Neurological Disorders
parkinsons · United StatesCOMPLETED

NCT00360009Effects of Deep Brain Stimulation on Motor, Mood, and Cognitive Symptoms in Parkinson's Disease
parkinsons · United StatesNA

NCT02275715Treatment of Feeding Problems in Children With Autism
autism · United StatesNA

NCT03456687Effects of Exenatide on Motor Function and the Brain
parkinsons · United StatesPHASE1

NCT06670794Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Drinking
substance_use · NA

NCT02225847Effect of Gardening on Brain Activity
depression · United StatesNA

NCT00375089Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity
other_neurology · United StatesCOMPLETED

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →